Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M, Paluchowski P, Solbach C, Blohmer JU, Kühn T, The Axsana Study Group (2021) Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study. Cancers (Basel) 13(7):1565.https://doi.org/10.3390/cancers13071565

Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM (2016) Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 34(10):1072–1078. https://doi.org/10.1200/jco.2015.64.0094

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swarnkar PK, Tayeh S, Michell MJ, Mokbel K (2021) The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systematic review and pooled analysis. Cancers (Basel) 13(7):1539. https://doi.org/10.3390/cancers13071539

Article  PubMed  Google Scholar 

Hartmann S, Stachs A, Kühn T, de Boniface J, Banys-Paluchowski M, Reimer T (2021) Targeted removal of axillary lymph nodes after carbon marking in patients with breast cancer treated with primary chemotherapy. Geburtshilfe Frauenheilkd 81(10):1121–1127. https://doi.org/10.1055/a-1471-4234

Article  PubMed  PubMed Central  Google Scholar 

Kuemmel S, Heil J, Rueland A, Seiberling C, Harrach H, Schindowski D, Lubitz J, Hellerhoff K, Ankel C, Graßhoff ST, Deuschle P, Hanf V, Belke K, Dall P, Dorn J, Kaltenecker G, Kuehn T, Beckmann U, Potenberg J, Blohmer JU, Kostara A, Breit E, Holtschmidt J, Traut E, Reinisch M (2022) A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients. Ann Surg 276(5):e553–e562. https://doi.org/10.1097/sla.0000000000004572

Article  PubMed  Google Scholar 

Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A (2018) Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol 44(9):1307–1311. https://doi.org/10.1016/j.ejso.2018.05.035

Article  PubMed  Google Scholar 

Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, van Tinteren H, Sonke GS, Rutgers EJ, Vrancken Peeters MJ (2015) Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg 261(2):378–382. https://doi.org/10.1097/sla.0000000000000558

Article  PubMed  Google Scholar 

Simons JM, van Nijnatten TJA, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, Kam BLR, Lobbes MBI, de Boer M, Verhoef C, Sars PRA, Heijmans HJ, van Haaren ERM, Vles WJ, Contant CME, Menke-Pluijmers MBE, Smit LHM, Kelder W, Boskamp M, Koppert LB, Luiten EJT, Smidt ML (2022) Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. JAMA Surg 157(11):991–999. https://doi.org/10.1001/jamasurg.2022.3907

Article  PubMed  PubMed Central  Google Scholar 

Malter W, Eichler C, Hanstein B, Mallmann P, Holtschmidt J (2020) First reported use of radiofrequency identification (RFID) technique for targeted excision of suspicious axillary lymph nodes in early stage breast cancer—evaluation of feasibility and review of current recommendations. In Vivo 34(3):1207–1213. https://doi.org/10.21873/invivo.11894

Baker JL, Haji F, Kusske AM, Fischer CP, Hoyt AC, Thompson CK, Lee MK, Attai D, DiNome ML (2022) SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study. Breast Cancer Res Treat 191(1):107–114. https://doi.org/10.1007/s10549-021-06416-z

Article  CAS  PubMed  Google Scholar 

Gallagher KK, Iles K, Kuzmiak C, Louie R, McGuire KP, Ollila DW (2022) Prospective evaluation of radar-localized reflector-directed targeted axillary dissection in node-positive breast cancer patients after neoadjuvant systemic therapy. J Am Coll Surg 234(4):538–545. https://doi.org/10.1097/xcs.0000000000000098

Article  PubMed  Google Scholar 

Žatecký J, Kubala O, Jelínek P, Lerch M, Ihnát P, Peteja M, Brát R (2020) Magnetic marker localization in breast cancer surgery. Arch Med Sci 19(1):122–127. https://doi.org/10.5114/aoms.2020.93673

Article  PubMed  PubMed Central  Google Scholar 

Banys-Paluchowski M, Kühn T, Masannat Y, Rubio I, de Boniface J, Ditsch N, Karadeniz Cakmak G, Karakatsanis A, Dave R, Hahn M, Potter S, Kothari A, Gentilini OD, Gulluoglu BM, Lux MP, Smidt M, Weber WP, Aktas Sezen B, Krawczyk N, Hartmann S, Di Micco R, Nietz S, Malherbe F, Cabioglu N, Canturk NZ, Gasparri ML, Murawa D, Harvey J (2023) Localization techniques for non-palpable breast lesions: current status, knowledge gaps, and rationale urope MELODY study (EUBREAST-4/iBRA-NET, NCT 05559411). Cancers (Basel) 15(4):1173. https://doi.org/10.3390/cancers15041173

Petrillo A, Di Giacomo R, Esposito E, Vallone P, Setola SV, Raso MM, Granata V, Barretta ML, Siani C, Rinaldo C, Donzelli I, Marone U, Melucci MT, Fucito A, Saponara R, Di Bonito M, Fusco R, Rinaldo M, Avino F (2022) Preoperative urope ation of nonpalpable breast lesions using magnetic markers in a tertiary cancer centre. Eur Radiol Exp 6(1):28. https://doi.org/10.1186/s41747-022-00280-2

Article  PubMed  PubMed Central  Google Scholar 

Magseed® S. (2023) Magnetic marker approved for any soft tissue and long-term implantation across urope. https://www.sysmex-europe.com/company/news-and-events/news-listings/news-details/magseedr-magnetic-marker-approved-for-any-soft-tissue-and-long-term-implantation-across-europe.html. Accessed on 24 Apr 2023

Barry PA, Harborough K, Sinnett V, Heeney A, St John ER, Gagliardi T, Bhaludin BN, Downey K, Pope R, O’Connell RL, Tasoulis MK, MacNeill F, Rusby JE, Gui G, Micha A, Chen S, Krupa CKD (2023) Clinical utility of axillary nodal markers in breast cancer. Eur J Surg Oncol 49(4):709–715. https://doi.org/10.1016/j.ejso.2022.12.019

Article  PubMed  Google Scholar 

Martínez M, Jiménez S, Guzmán F, Fernández M, Arizaga E, Sanz C (2022) Evaluation of axillary lymph node marking with Magseed® before and after neoadjuvant systemic therapy in breast cancer patients: MAGNET Study. Breast J 2022:6111907. https://doi.org/10.1155/2022/6111907

Article  PubMed  PubMed Central  Google Scholar 

Miller ME, Patil N, Li P, Freyvogel M, Greenwalt I, Rock L, Simpson A, Teresczuk M, Carlisle S, Peñuela M, Thompson CL, Shenk R, Dietz J (2021) Hospital system adoption of magnetic seeds for wireless breast and lymph node localization. Ann Surg Oncol 28(6):3223–3229. https://doi.org/10.1245/s10434-020-09311-x

Article  PubMed  Google Scholar 

Simons JM, Scoggins ME, Kuerer HM, Krishnamurthy S, Yang WT, Sahin AA, Shen Y, Lin H, Bedrosian I, Mittendorf EA, Thompson A, Lane DL, Hunt KK, Caudle AS (2021) Prospective registry trial assessing the use of magnetic seeds to locate clipped nodes after neoadjuvant chemotherapy for breast cancer patients. Ann Surg Oncol 28(8):4277–4283. https://doi.org/10.1245/s10434-020-09542-y

Article  PubMed  Google Scholar 

Reitsamer R, Peintinger F, Forsthuber E, Sir A (2021) The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy. Breast 57:113–117. https://doi.org/10.1016/j.breast.2021.03.008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mariscal Martínez A, Vives Roselló I, Salazar Gómez A, Catanese A, Pérez Molina M, Solà Suarez M, Pascual Miguel I, Blay Aulina L, Ríos Gozálvez C, Julián Ibáñez JF, Rodríguez Martínez P, Martínez Román S, Margelí Vila M, Luna Tomás MA (2021) Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer. Surg Oncol 36:28–33. https://doi.org/10.1016/j.suronc.2020.11.013

Article  PubMed  Google Scholar 

McCamley C, Ruyssers N, To H, Tsao S, Keane H, Poliness C, Mehta K, Rose A, Baker C, Mann GB (2021) Multicentre evaluation of magnetic technology for localization of non-palpable breast lesions and targeted axillary nodes. ANZ J Surg 91(11):2411–2417. https://doi.org/10.1111/ans.17108

Article  PubMed  Google Scholar 

Žatecký J, Kubala O, Coufal O, Kepičová M, Faridová A, Rauš K, Lerch M, Peteja M, Brát R (2021) Magnetic seed (Magseed) localization in breast cancer surgery: a multicentre clinical trial. Breast Care (Basel) 16(4):383–388. https://doi.org/10.1159/000510380

Article  PubMed  Google Scholar 

Laws A, Dillon K, Kelly BN, Kantor O, Hughes KS, Gadd MA, Smith BL, Lamb LR, Specht M (2020) Node-positive patients treated with neoadjuvant chemotherapy can be spared axillary lymph node dissection with wireless non-radioactive localizers. Ann Surg Oncol 27(12):4819–4827. https://doi.org/10.1245/s10434-020-08902-y

Article  PubMed  Google Scholar 

Greenwood HI, Wong JM, Mukhtar RA, Alvarado MD, Price ER (2019) Feasibility of magnetic seeds for preoperative localization of axillary lymph nodes in breast cancer treatment. AJR Am J Roentgenol 213(4):953–957. https://doi.org/10.2214/ajr.19.21378

Article  PubMed  Google Scholar 

García-Moreno JL, Benjumeda-Gonzalez AM, Amerigo-Góngora M, Landra-Dulanto PJ, Gonzalez-Corena Y, Gomez-Menchero J (2019) Targeted axillary dissection in breast cancer by marking lymph node metastasis with a magnetic seed before starting neoadjuvant treatment. J Surg Case Rep 2019(11):rjz344. https://doi.org/10.1093/jscr/rjz344

Rodriguez Gallo E, Vives I, Alonso I, Caparros FX, Ganau S, Bargallo X, Ubeda B, Perissinotti A, Tapias A, Vidal-Sicart S (2018) A novel dual technique combining radiotracer and magnetism for restaging axilla after neoadjuvant therapy in axillary node-positive breast cancer patients. J Nucl Med Radiat Ther 9(6):387. https://doi.org/10.4172/2155-9619.1000387

Article  Google Scholar 

Axillary Surgery After NeoAdjuvant Treatment (2023) AXSANA. https://clinicaltrials.gov/ct2/show/NCT04373655. Accessed on 24 Apr 2023

Sahoo S, Lester SC (2009) Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med 133(4):633–642. https://doi.org/10.5858/133.4.633

Article  PubMed  Google Scholar 

Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F, Vicini E, Morigi C, Corso G, Intra M, Canegallo F, Ratini S, Leonardi MC, La Rocca E, Bagnardi V, Montagna E, Colleoni M, Viale G, Bottiglieri L, Grana CM, Biasuz JV, Veronesi P, Galimberti V (2021) Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up. Eur J Surg Oncol 47(4):804–812. https://doi.org/10.1016/j.ejso.2020.10.014

Article  PubMed  Google Scholar 

Kuemmel S, Heil J, Bruzas S, Breit E, Schindowski D, Harrach H, Chiari O, Hellerhoff K, Bensmann E, Hanf V, Graßhoff ST, Deuschle P, Belke K, Polata S, Paepke S, Warm M, Meiler J, Schindlbeck C, Ruhwedel W, Beckmann U, Groh U, Dall P, Blohmer JU, Traut A, Reinisch M (2023) Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer. JAMA Surg. https://doi.org/10.1001/jamasurg.2023.1772

Montagna G, Mrdutt M, Botty A, Barrio AV, Sevilimedu V, Boughey JC, Hoskin TL, Rosenberger LH, Hwang ES, Ingham A, Papassotiropoulos B, Nguyen-Sträuli BD, Kurzeder C, Aybar DD, Vorburger D, Matlac DM, Ostapenko E, Riedel F, Fitzal F, Meani F, Fick F, Sagasser J, Heil J, Dedes KJ, Romics L, Banys-Paluchowski M, Del Rosario Cueva Perez M, Diaz MC, Heidinger M, Fehr MK, Reinisch M, Maggi N, Rocco N, Ditsch N, Gentilini OD, Paulinelli RR, Zarhi SS, Küemmel S, Bruzas S, Di Lascio S, Parissenti T, Güth U, Ovalle V, Tausch C, MorrowM, Kühn T, Weber WP (2022) Oncological outcomes following omission of axillary lymph node dissection in node-positive patients downstaging to node negative with neoadjuvant chemotherapy: the OPBC-04/EUBREAST-06/OMA study. Cancer Res 83(5_Supplement):GS4-02. https://doi.org/10.1158/1538-7445.SABCS22-GS4-02

Gasparri ML, de Boniface J, Poortmans P, Gentilini OD, Kaidar-Person O, Banys-Paluchowski M, Di Micco R, Niinikoski L, Murawa D, Bonci EA, Pasca A, Rubio IT, Karadeniz Cakmak G, Kontos M, Kühn T (2022) Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey. Br J Surg 109(9):857–863. https://doi.org/10.1093/bjs/znac217

Article  PubMed  Google Scholar 

Song YX, Xu Z, Liang MX, Liu Z, Hou JC, Chen X, Xu D, Fei YJ, Tang JH (2022) Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis. Cancer Med 11(22):4085–4103. https://doi.org/10.1002/cam4.4769

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gera R, Tayeh S, Al-Reefy S, Mokbel K (2020) Evolving role of magseed in wireless localization of breast lesions: Systematic review and pooled analysis of 1,559 procedures. Anticancer Res 40(4):1809–1815. https://doi.org/10.21873/anticanres.14135

De